Anxiety is a prevalent and serious mental health disorder affecting millions of Americans. According to the National Institute of Mental Health, almost one-third of adults will experience an anxiety disorder at some point in their lives. For those with anxiety disorders, the symptoms can be debilitating, interfering with daily activities such as work and relationships.
- If you don’t take a look, you’ll miss out: The list of startups you can invest in is here. Click here to take the leap into the world of startup investing.
TruBrain, a cognitive healthcare company, recently launched a new wearable technology aimed at tackling anxiety. Designed by Ph.D. neuroscientists and notable European industrial designers, the smart wearable uses established technology that has been cleared by the Food and Drug Administration (FDA) to send safe, micro-electric currents to key parts of the brain, increasing blood flow and promoting calm. With a market size of $11 billion, TruBrain’s launch of this innovative product is a significant development in the field of cognitive healthcare.
TruBrain CEO Chris Thompson said, “Our mission is to empower people to do their best thinking. The problems we’re trying to solve are stress and anxiety. That will clear the runway for you to focus more, relax and get better sleep.”
The wearable technology is backed by thousands of scientific studies and decades of research, providing neurostimulation that can produce results in as little as 30 minutes.
TruBrain’s success as a profitable brand is evident, with over $20 million in lifetime sales and a distribution network of grassroots investors. The company’s personalized drinks package, developed by a team of University of California neuroscientists, is also a popular product.
The startup launched on StartEngine, a popular startup investing platform, and has since grown to one of the largest campaigns by amount raised on the site. The success comes after a number of notable events in the industry. For example, Elon Musk-backed Neuralink has received approval to test its devices on humans, and received hundreds of millions in investments to do it. Similarly, Amazon.com, Inc. founder Jeff Bezos and Microsoft Corp. founder Bill Gates invested in Neuralink competitor Synchron.
With its innovative wearable technology and science-backed personalized drinks package, TruBrain is well on its way to becoming the leading cognitive healthcare brand, empowering people to achieve their best thinking and live their best lives.
Reg A+ offering made available through StartEngine Crowdfunding, Inc. No broker-dealer or intermediary involved in offering. This investment is speculative, illiquid, and involves a high degree of risk, including the possible loss of your entire investment. Please see the most recent Supplement, Offering Circular and Related Risks for more information.
Benzinga may receive monetary compensation from the issuer, or its agency, for publicizing the offering of the issuer’s securities. This content is for informational purposes only and is not intended to be investing advice. This is a paid ad. Please see 17b disclosure linked in the campaign page for more information.
